Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim IntfiledCriticalBoehringer Ingelheim Int
Publication of UY29303A1publicationCriticalpatent/UY29303A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere al uso de indolinonas de fórmula general sustituidas en la posición 6, en donde R1 a R5 y X se definen según la reivindicación 1, sus isómeros y sus sales, particularmente sus sales fisiológicamente aceptables, en calidad de un medicamento para la prevención o el tratamiento de enfermedades fibróticas específicas.The present invention relates to the use of indolinones of general formula substituted in position 6, wherein R1 to R5 and X are defined according to claim 1, their isomers and their salts, particularly their physiologically acceptable salts, as a medicament for the prevention or treatment of specific fibrotic diseases.
UY29303A2004-12-242005-12-22
MEDICATIONS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
UY29303A1
(en)